iRhythm Technologies to Present at the Canaccord Genuity 42nd Annual Growth Conference
iRhythm’s management is scheduled to present on
iRhythm is a leading digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change the clinical management of patients.
Investor Relations Contact
iRhythm Media Contact